"According to a press release, GW Pharmaceuticals will hold the patent rights to the two primary compounds found in marijuana, THC and CBD, for use as medicine for patients suffering from gliomas -- the most common form of malignant brain tumor. The United States Patent Office informed the drug company earlier last week, by way of Notice of Allowance, that a patent application filed several years ago was officially deemed a genuine invention and is now in its final stages of approval."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.